Deals in Depth: May 2008
Executive Summary
May 2008 dealmaking highlights: BMS stood out, getting a Phase II cardiovascular agent from KAI, selling off its ConvaTec wound healing division to private equity, and acquiring Kosan BioSciences; total private placement dollars in biopharma companies ($496mm) was almost half what it was in the previous month, while private investments in device players were up 67% to $278mm.